Literature DB >> 10470045

Defining the requirements for immunological control of mycobacterial infections.

P J Murray1.   

Abstract

Tuberculosis remains a major public health problem throughout the world. Research into the immunological basis of the host-pathogen relationship has recently benefited from the fascinating convergence of genetic data from mouse models and from humans. Latency - the seemingly quiescent phase of bacterial persistence - is the central problem in controlling tuberculosis and will be the next frontier of research.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10470045     DOI: 10.1016/s0966-842x(99)01567-x

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  22 in total

1.  Comparative analysis of multiple genome-scale data sets.

Authors:  Margaret Werner-Washburne; Brian Wylie; Kevin Boyack; Edwina Fuge; Judith Galbraith; Jose Weber; George Davidson
Journal:  Genome Res       Date:  2002-10       Impact factor: 9.043

2.  Mycobacterial bacilli are metabolically active during chronic tuberculosis in murine lungs: insights from genome-wide transcriptional profiling.

Authors:  Adel M Talaat; Sarah K Ward; Chia-Wei Wu; Elizabeth Rondon; Christine Tavano; John P Bannantine; Rick Lyons; Stephen A Johnston
Journal:  J Bacteriol       Date:  2007-03-23       Impact factor: 3.490

Review 3.  Cellular quiescence in budding yeast.

Authors:  Siyu Sun; David Gresham
Journal:  Yeast       Date:  2021-01-25       Impact factor: 3.239

4.  Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies.

Authors:  Gregory D Hussey; Marcia L V Watkins; Elizabeth A Goddard; Sean Gottschalk; Elizabeth J Hughes; Karen Iloni; Maurice A Kibel; Stanley R Ress
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

5.  CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals.

Authors:  Matthew W Auten; Weitao Huang; Guixiang Dai; Alistair J Ramsay
Journal:  Vaccine       Date:  2012-02-18       Impact factor: 3.641

6.  Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation.

Authors:  I S Leal; B Smedegård; P Andersen; R Appelberg
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

7.  Transgenic mice expressing human interleukin-10 in the antigen-presenting cell compartment show increased susceptibility to infection with Mycobacterium avium associated with decreased macrophage effector function and apoptosis.

Authors:  Carl G Feng; Marika C Kullberg; Dragana Jankovic; Allen W Cheever; Patricia Caspar; Robert L Coffman; Alan Sher
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

8.  In situ study of abundant expression of proinflammatory chemokines and cytokines in pulmonary granulomas that develop in cynomolgus macaques experimentally infected with Mycobacterium tuberculosis.

Authors:  Craig L Fuller; JoAnne L Flynn; Todd A Reinhart
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

9.  Effect of multiple genetic polymorphisms on antigen presentation and susceptibility to Mycobacterium tuberculosis infection.

Authors:  Stewart T Chang; Jennifer J Linderman; Denise E Kirschner
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

10.  Characterization of differentiated quiescent and nonquiescent cells in yeast stationary-phase cultures.

Authors:  Anthony D Aragon; Angelina L Rodriguez; Osorio Meirelles; Sushmita Roy; George S Davidson; Phillip H Tapia; Chris Allen; Ray Joe; Don Benn; Margaret Werner-Washburne
Journal:  Mol Biol Cell       Date:  2008-01-16       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.